14-day Susceptibility-guided Bismuth Quadruple Therapy for Multiple Drug Resistant H. Pylori Infection

Clinical trial NCT06687499 · COMPLETED

Trial details

NCT number: NCT06687499
Sponsor: National Cheng-Kung University Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Helicobacter Pylori Drug Resistance, Multiple

Start date: 2022-08-22
Primary completion: 2023-12-31
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.